Snapshot

The Sanitary Registration of Orphan Medicines pathway has been developed by the Instituto de Salud Pública de Chile of Chile.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from EU-EMA United States

Review times: 6 - 12 months.